| Hang Seng Index | 25.200 HKD | +0.200 | +0.800% | 271.65M | 6.86B | 24.992 (+0.832%) HKD as at 2025/07/17 | | |
| Hang Seng China Enterprises | 91.520 HKD | +0.760 | +0.837% | 63.58M | 5.83B | 90.630 (+0.982%) HKD as at 2025/07/17 | | |
| Hang Seng TECH Index | 5.410 HKD | +0.055 | +1.027% | 488.54M | 2.65B | 5.354 (+1.052%) HKD as at 2025/07/17 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.480 HKD | +0.115 | +2.144% | 119.20M | 659.61M | 5.385 (+1.764%) HKD as at 2025/07/17 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.592 HKD | -0.036 | -2.211% | 282.26M | 444.66M | 1.623 (-1.892%) HKD as at 2025/07/17 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.084 HKD | -0.038 | -1.791% | 70.73M | 146.77M | 2.131 (-2.201%) HKD as at 2025/07/17 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.590 HKD | +0.100 | +1.821% | 22.77M | 127.73M | 5.466 (+2.270%) HKD as at 2025/07/17 | | |
| Hang Seng TECH Index | 11.590 HKD | +0.130 | +1.134% | 5.71M | 66.53M | 11.412 (+1.556%) HKD as at 2025/07/16 | | |
| Hang Seng TECH Index | 5.485 HKD | +0.055 | +1.013% | 10.36M | 57.16M | 5.404 (+1.495%) HKD as at 2025/07/16 | | |
| Hang Seng China Enterprises | 10.730 HKD | +0.040 | +0.374% | 4.24M | 45.47M | 10.648 (+0.768%) HKD as at 2025/07/16 | | |
| CSI 300 | 46.320 HKD | +0.400 | +0.871% | 388.20K | 17.97M | 46.094 (+0.489%) HKD as at 2025/07/17 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 15.720 HKD | -0.030 | -0.190% | 1.06M | 16.79M | 15.742 (-0.140%) HKD as at 2025/07/17 | | |
| FTSE China A50 | 14.730 HKD | +0.130 | +0.890% | 959.30K | 14.10M | 14.601 (+0.884%) HKD as at 2025/07/16 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 8.640 HKD | +0.350 | +4.222% | 1.32M | 11.47M | 8.254 (+4.680%) HKD as at 2025/07/17 | | |
| CSI RAFI 50 | 8.030 HKD | +0.179 | +2.280% | 1.39M | 11.21M | N/A | | |
| CSI Hong Kong Dividend | 37.200 HKD | +0.340 | +0.922% | 292.70K | 10.85M | 36.845 (+0.964%) HKD as at 2025/07/17 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.890 HKD | -0.052 | -1.319% | 2.68M | 10.42M | 3.957 (-1.696%) HKD as at 2025/07/16 | | |
| CME Ether Futures | 17.180 HKD | +0.660 | +3.995% | 584.50K | 10.07M | 16.164 (+6.288%) HKD as at 2025/07/16 | | |
| FTSE US Treasury 20+ Years Index | 66.800 HKD | +0.480 | +0.724% | 142.65K | 9.52M | 67.353 (-0.821%) HKD as at 2025/07/16 | | |
| London Gold Fixing Price | 2,414.000 HKD | +9.000 | +0.374% | 3.05K | 7.35M | N/A | | |
| Hang Seng High Dividend Yield | 29.060 HKD | +0.140 | +0.484% | 243.70K | 7.08M | 28.956 (+0.358%) HKD as at 2025/07/16 | | |
| FTSE China A50 | 13.740 HKD | +0.140 | +1.029% | 503.50K | 6.90M | 13.634 (+0.778%) HKD as at 2025/07/17 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 14.900 HKD | +0.220 | +1.499% | 424.00K | 6.32M | 14.631 (+1.841%) HKD as at 2025/07/17 | | |
| Solactive China Biotech Index NTR | 70.360 HKD | +0.060 | +0.085% | 85.04K | 6.01M | 67.464 (+4.292%) HKD as at 2025/07/16 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.472 HKD | +0.064 | +1.878% | 1.57M | 5.46M | 3.393 (+2.316%) HKD as at 2025/07/17 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng China Enterprises | 1.594 HKD | -0.036 | -2.209% | 3.01M | 4.80M | 1.636 (-2.549%) HKD as at 2025/07/17 | | |
| CME Bitcoin Futures | 40.960 HKD | +0.600 | +1.487% | 110.10K | 4.51M | 40.654 (+0.753%) HKD as at 2025/07/16 | | |
| Hang Seng Index | 25.340 HKD | +0.300 | +1.198% | 104.00K | 2.64M | 25.066 (+1.093%) HKD as at 2025/07/17 | | |
| NASDAQ-100 Index | 47.140 HKD | +0.340 | +0.726% | 48.80K | 2.30M | 46.769 (+0.793%) HKD as at 2025/07/16 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 4.196 HKD | +0.014 | +0.335% | 541.10K | 2.29M | 4.054 (+3.495%) HKD as at 2025/07/16 | | |